Landscapes / Companies

Chiesi Farmaceutici S.p.A. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 approved
1 in Phase 3
Next date
CHF6467, Phase 1 trial completes
Drugs
10
in active trials · 41 in all
Trials
15 active
96 since 2021

Drugs10

DrugHow it worksPartnerStageNext dateDetails
—
On the market 3 Jun 2027Phase 2 trial completes
—
Protalix
Approved Oct 2027Phase 2/3 trial completes
Leptin analog
Approved Feb 2028Phase 4 trial completes
—
Approved in the EU 13 Jun 2028Phase 4 trial completes
—
Approved —
—
Haisco Pharmaceutical Group
Phase 3 Apr 2030Phase 3 trial completes
—
Phase 2 27 Jun 2028Phase 2 trial completes
—
Phase 1 28 Feb 2027Phase 1 trial completes
—
Phase 1 Aug 2027Phase 1 trial completes
—
Phase 1 27 Dec 2027Phase 1 trial completes

About

No active trial
31 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Chiesi Farmaceutici S.p.A.

Following is part of Solo: you see every change to Chiesi Farmaceutici S.p.A. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in